Conclusions: Prevalence of obesity is increasing, and use of GLP-1 RAs as the preferred antiobesity medication has increased ...
Reimaging professional and educational practices for an AI-augmented future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results